|
Exploring the link between mutant RNA expression and trinucleotide repeat disease |
5 F31 EY030336-03 |
JOHNSON, SAMANTHA TORI |
NEI |
2021 |
|
GENE THERAPY OF CORNEAL DYSTROPHY: LYSOSOMAL STORAGE DISEASES |
1R01EY029427-01A1 |
KAO, WINSTON W |
NEI |
2019 |
|
DOWN SYNDROME, EARLY CATARACTS, EYE DISEASES, AND BETA-AMYLOID CONFORMERS |
1R21EY031277-01 |
CHANG, GEOFFREY A |
NEI |
2019 |
|
THE ROLE OF AREA V4 IN THE PERCEPTION AND RECOGNITION OF VISUAL OBJECTS |
2R01EY018839-10 |
PASUPATHY, ANITHA |
NEI |
2019 |
|
MECHANISMS OF VISUAL ENCODING AND PLASTICITY IN ANTERIOR CINGULATE CORTEX |
5K99EY028964-02 |
SIDOROV, MICHAEL S |
NEI |
2019 |
|
MECHANISMS OF SYNAPTIC SPECIFICITY IN VISUAL CIRCUITS |
5R01EY025627-05 |
TRIPLETT, JASON |
NEI |
2019 |
|
ACTIVATION OF THE ANGIOPOIETIN-TIE2 PATHWAY TO TREAT OCULAR HYPERTENSION AND GLAUCOMA |
5R01EY025799-04 |
QUAGGIN, SUSAN E. |
NEI |
2019 |
|
RAPALOG THERAPY IN HERITABLE AND VIGABATRIN-INDUCED GABA METABOLIC DISORDERS |
5R01EY027476-03 |
GIBSON, K MICHAEL |
NEI |
2019 |
|
MECHANISMS OF SYNAPTIC SPECIFICITY IN VISUAL CIRCUITS |
5R01EY025627-04 |
TRIPLETT, JASON |
NEI |
2018 |
|
ACTIVATION OF THE ANGIOPOIETIN-TIE2 PATHWAY TO TREAT OCULAR HYPERTENSION AND GLAUCOMA |
5R01EY025799-03 |
QUAGGIN, SUSAN E. |
NEI |
2018 |